NASDAQ: MGX - Metagenomi, Inc.

Yield per half year: -11.58%
Dividend yield: 0.00%
Sector: Healthcare

Metagenomi, Inc.

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
0/10
0 57.27 -100% 0 0%
P/S 0 33.44 -100%
P/BV 0 4.64 -100%
P/FCF 0 42.53 -100%
Ev/Ebitda 1.57 -17.68 -108.87%
Ev/S -2.06 22.59 -109.13%
Ev/FCF 0.9126 47.55 -98.08%
E/P 0 0.0182 -100%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
0/10
-131.58 -14.2 826.39% -2540.19 -94.82%
ROE 50.34 9.78 414.6%
ROA -18.71 0.33 -5768.28%
ROIC 0 7.63 -100%
ROS -152.5 -26.41 477.35%
ROCE 46.54 14.5 220.93%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
10/10
-0.819 -3.87 -78.86% -0.8579 -4.54%
Nеt Debt/Ebitda 1.57 -4.24 -136.99%
Debt/Ratio 0.1322 0.1853 -28.66%
Debt/Equity 0 1.56 -100%
Debt/Net Income -0.7066 10.06 -107.02%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
0/10
0 0.5351 -100% 0 0%
Number of years of dividend growth 0 0.7368 -100%
DSI 0 0.235 -100%
Average dividend growth 0 1.41 -100%
Average percentage for 5 years 0 0.486 -100%
Average percentage for payments 0 43.64 -100%
Difference from average difference in sector -0.5351

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
10/10
18318.11 30.62 59724%
Growth impulse Ebitda in 5 years 138.26 -17.42 -893.69%
Growth impulse Net Income in 5 years 218.95 -52.26 -518.96%
Growth impulse FCF in 5 years -573 -31.68 1708.71%
Growth impulse EPS in 5 years 218.3 -61.82 -453.12%
IP Score
4.9/10

Similar companies

Alexion

Amgen

ABIOMED

Gilead Sciences

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription